nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—CYP3A7—Progesterone—uterine cancer	0.0907	0.148	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0907	0.148	CbGbCtD
Voriconazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0689	0.112	CbGbCtD
Voriconazole—CYP3A5—Progesterone—uterine cancer	0.0681	0.111	CbGbCtD
Voriconazole—CYP2C19—Progesterone—uterine cancer	0.0549	0.0895	CbGbCtD
Voriconazole—PTGS1—Etoposide—uterine cancer	0.0508	0.0828	CbGbCtD
Voriconazole—CYP2C9—Progesterone—uterine cancer	0.0457	0.0744	CbGbCtD
Voriconazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0401	0.0653	CbGbCtD
Voriconazole—CYP3A5—Etoposide—uterine cancer	0.0305	0.0497	CbGbCtD
Voriconazole—CYP3A4—Progesterone—uterine cancer	0.0265	0.0433	CbGbCtD
Voriconazole—CYP2B6—Doxorubicin—uterine cancer	0.0264	0.043	CbGbCtD
Voriconazole—CYP3A4—Etoposide—uterine cancer	0.0119	0.0194	CbGbCtD
Voriconazole—CYP3A4—Doxorubicin—uterine cancer	0.0081	0.0132	CbGbCtD
Voriconazole—PTGS1—oviduct—uterine cancer	0.00254	0.0773	CbGeAlD
Voriconazole—FMO1—uterine cervix—uterine cancer	0.00234	0.0712	CbGeAlD
Voriconazole—FMO1—renal system—uterine cancer	0.00219	0.0666	CbGeAlD
Voriconazole—FMO1—endometrium—uterine cancer	0.00212	0.0644	CbGeAlD
Voriconazole—FMO1—mammalian vulva—uterine cancer	0.00205	0.0623	CbGeAlD
Voriconazole—FMO3—mammalian vulva—uterine cancer	0.00177	0.0538	CbGeAlD
Voriconazole—PTGS1—artery—uterine cancer	0.00168	0.0512	CbGeAlD
Voriconazole—FMO1—female gonad—uterine cancer	0.0016	0.0485	CbGeAlD
Voriconazole—FMO1—vagina—uterine cancer	0.00159	0.0482	CbGeAlD
Voriconazole—FMO3—vagina—uterine cancer	0.00137	0.0417	CbGeAlD
Voriconazole—FMO1—lymph node—uterine cancer	0.00103	0.0312	CbGeAlD
Voriconazole—FMO3—lymph node—uterine cancer	0.000887	0.027	CbGeAlD
Voriconazole—CYP3A5—uterine cervix—uterine cancer	0.000704	0.0214	CbGeAlD
Voriconazole—CYP3A5—renal system—uterine cancer	0.000659	0.02	CbGeAlD
Voriconazole—CYP2B6—renal system—uterine cancer	0.000655	0.0199	CbGeAlD
Voriconazole—PTGS1—epithelium—uterine cancer	0.000638	0.0194	CbGeAlD
Voriconazole—PTGS1—uterine cervix—uterine cancer	0.000633	0.0192	CbGeAlD
Voriconazole—PTGS1—smooth muscle tissue—uterine cancer	0.000615	0.0187	CbGeAlD
Voriconazole—CYP2C19—vagina—uterine cancer	0.000606	0.0184	CbGeAlD
Voriconazole—PTGS1—renal system—uterine cancer	0.000592	0.018	CbGeAlD
Voriconazole—PTGS1—endometrium—uterine cancer	0.000572	0.0174	CbGeAlD
Voriconazole—PTGS1—mammalian vulva—uterine cancer	0.000554	0.0168	CbGeAlD
Voriconazole—PTGS1—uterus—uterine cancer	0.000528	0.016	CbGeAlD
Voriconazole—CYP2B6—female reproductive system—uterine cancer	0.000525	0.0159	CbGeAlD
Voriconazole—CYP2C9—female reproductive system—uterine cancer	0.000519	0.0158	CbGeAlD
Voriconazole—CYP3A4—renal system—uterine cancer	0.000495	0.015	CbGeAlD
Voriconazole—CYP3A5—female gonad—uterine cancer	0.00048	0.0146	CbGeAlD
Voriconazole—CYP3A5—vagina—uterine cancer	0.000477	0.0145	CbGeAlD
Voriconazole—CYP2B6—vagina—uterine cancer	0.000474	0.0144	CbGeAlD
Voriconazole—PTGS1—female reproductive system—uterine cancer	0.000474	0.0144	CbGeAlD
Voriconazole—PTGS1—female gonad—uterine cancer	0.000432	0.0131	CbGeAlD
Voriconazole—PTGS1—vagina—uterine cancer	0.000429	0.013	CbGeAlD
Voriconazole—CYP3A4—female reproductive system—uterine cancer	0.000396	0.012	CbGeAlD
Voriconazole—PTGS1—lymph node—uterine cancer	0.000277	0.00843	CbGeAlD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000134	0.0041	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	0.000134	0.00409	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	0.000132	0.00405	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—AKR1B1—uterine cancer	0.000132	0.00404	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—STAR—uterine cancer	0.000132	0.00404	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	0.000132	0.00403	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—SRD5A2—uterine cancer	0.00013	0.004	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—NDUFB11—uterine cancer	0.00013	0.004	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—CYP11A1—uterine cancer	0.000129	0.00397	CbGpPWpGaD
Voriconazole—Dry skin—Doxorubicin—uterine cancer	0.000129	0.000402	CcSEcCtD
Voriconazole—Hyperhidrosis—Etoposide—uterine cancer	0.000129	0.000402	CcSEcCtD
Voriconazole—Pancreatitis—Epirubicin—uterine cancer	0.000129	0.000402	CcSEcCtD
Voriconazole—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000129	0.0004	CcSEcCtD
Voriconazole—Hypokalaemia—Doxorubicin—uterine cancer	0.000128	0.000399	CcSEcCtD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000128	0.00392	CbGpPWpGaD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000128	0.00391	CbGpPWpGaD
Voriconazole—Anorexia—Etoposide—uterine cancer	0.000127	0.000396	CcSEcCtD
Voriconazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000127	0.000395	CcSEcCtD
Voriconazole—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000127	0.000395	CcSEcCtD
Voriconazole—Diarrhoea—Dactinomycin—uterine cancer	0.000126	0.000393	CcSEcCtD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000126	0.00385	CbGpPWpGaD
Voriconazole—Pancytopenia—Epirubicin—uterine cancer	0.000125	0.000389	CcSEcCtD
Voriconazole—Hypotension—Etoposide—uterine cancer	0.000125	0.000388	CcSEcCtD
Voriconazole—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	0.000124	0.00381	CbGpPWpGaD
Voriconazole—Muscular weakness—Doxorubicin—uterine cancer	0.000124	0.000387	CcSEcCtD
Voriconazole—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000124	0.000387	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	0.000123	0.00377	CbGpPWpGaD
Voriconazole—Dysuria—Epirubicin—uterine cancer	0.000123	0.000383	CcSEcCtD
Voriconazole—Abdominal distension—Doxorubicin—uterine cancer	0.000123	0.000381	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000122	0.00375	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000122	0.00374	CbGpPWpGaD
Voriconazole—Influenza—Doxorubicin—uterine cancer	0.000122	0.000379	CcSEcCtD
Voriconazole—Dysphagia—Doxorubicin—uterine cancer	0.000122	0.000379	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.000121	0.0037	CbGpPWpGaD
Voriconazole—Eosinophilia—Doxorubicin—uterine cancer	0.000121	0.000375	CcSEcCtD
Voriconazole—Photosensitivity reaction—Epirubicin—uterine cancer	0.00012	0.000374	CcSEcCtD
Voriconazole—Paraesthesia—Etoposide—uterine cancer	0.00012	0.000373	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—AKR1C1—uterine cancer	0.00012	0.00366	CbGpPWpGaD
Voriconazole—Pancreatitis—Doxorubicin—uterine cancer	0.000119	0.000372	CcSEcCtD
Voriconazole—Dyspnoea—Etoposide—uterine cancer	0.000119	0.00037	CcSEcCtD
Voriconazole—Hyperglycaemia—Epirubicin—uterine cancer	0.000119	0.000369	CcSEcCtD
Voriconazole—Somnolence—Etoposide—uterine cancer	0.000119	0.000369	CcSEcCtD
Voriconazole—Pneumonia—Epirubicin—uterine cancer	0.000118	0.000367	CcSEcCtD
Voriconazole—Infestation NOS—Epirubicin—uterine cancer	0.000117	0.000365	CcSEcCtD
Voriconazole—Infestation—Epirubicin—uterine cancer	0.000117	0.000365	CcSEcCtD
Voriconazole—Vomiting—Dactinomycin—uterine cancer	0.000117	0.000365	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	0.000117	0.00358	CbGpPWpGaD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000116	0.00356	CbGpPWpGaD
Voriconazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000116	0.000362	CcSEcCtD
Voriconazole—Rash—Dactinomycin—uterine cancer	0.000116	0.000362	CcSEcCtD
Voriconazole—Decreased appetite—Etoposide—uterine cancer	0.000116	0.000361	CcSEcCtD
Voriconazole—Pancytopenia—Doxorubicin—uterine cancer	0.000116	0.00036	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000115	0.000359	CcSEcCtD
Voriconazole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000115	0.000358	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000115	0.00352	CbGpPWpGaD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000115	0.00351	CbGpPWpGaD
Voriconazole—Jaundice—Epirubicin—uterine cancer	0.000114	0.000356	CcSEcCtD
Voriconazole—Stomatitis—Epirubicin—uterine cancer	0.000114	0.000356	CcSEcCtD
Voriconazole—Pain—Etoposide—uterine cancer	0.000114	0.000355	CcSEcCtD
Voriconazole—Constipation—Etoposide—uterine cancer	0.000114	0.000355	CcSEcCtD
Voriconazole—Urinary tract infection—Epirubicin—uterine cancer	0.000114	0.000355	CcSEcCtD
Voriconazole—Conjunctivitis—Epirubicin—uterine cancer	0.000114	0.000355	CcSEcCtD
Voriconazole—Dysuria—Doxorubicin—uterine cancer	0.000114	0.000354	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000113	0.00345	CbGpPWpGaD
Voriconazole—Sweating—Epirubicin—uterine cancer	0.000112	0.00035	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.000112	0.00344	CbGpPWpGaD
Voriconazole—Haematuria—Epirubicin—uterine cancer	0.000112	0.000348	CcSEcCtD
Voriconazole—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000111	0.000346	CcSEcCtD
Voriconazole—Hepatobiliary disease—Epirubicin—uterine cancer	0.000111	0.000345	CcSEcCtD
Voriconazole—Epistaxis—Epirubicin—uterine cancer	0.000111	0.000344	CcSEcCtD
Voriconazole—Sinusitis—Epirubicin—uterine cancer	0.00011	0.000343	CcSEcCtD
Voriconazole—Feeling abnormal—Etoposide—uterine cancer	0.00011	0.000342	CcSEcCtD
Voriconazole—Hyperglycaemia—Doxorubicin—uterine cancer	0.00011	0.000342	CcSEcCtD
Voriconazole—Nausea—Dactinomycin—uterine cancer	0.00011	0.000341	CcSEcCtD
Voriconazole—Agranulocytosis—Epirubicin—uterine cancer	0.000109	0.000341	CcSEcCtD
Voriconazole—Pneumonia—Doxorubicin—uterine cancer	0.000109	0.00034	CcSEcCtD
Voriconazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000109	0.00034	CcSEcCtD
Voriconazole—Infestation NOS—Doxorubicin—uterine cancer	0.000109	0.000338	CcSEcCtD
Voriconazole—Infestation—Doxorubicin—uterine cancer	0.000109	0.000338	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000108	0.000335	CcSEcCtD
Voriconazole—Bradycardia—Epirubicin—uterine cancer	0.000107	0.000334	CcSEcCtD
Voriconazole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000106	0.000331	CcSEcCtD
Voriconazole—Urticaria—Etoposide—uterine cancer	0.000106	0.00033	CcSEcCtD
Voriconazole—Jaundice—Doxorubicin—uterine cancer	0.000106	0.000329	CcSEcCtD
Voriconazole—Stomatitis—Doxorubicin—uterine cancer	0.000106	0.000329	CcSEcCtD
Voriconazole—Rhinitis—Epirubicin—uterine cancer	0.000106	0.000329	CcSEcCtD
Voriconazole—Abdominal pain—Etoposide—uterine cancer	0.000105	0.000328	CcSEcCtD
Voriconazole—Body temperature increased—Etoposide—uterine cancer	0.000105	0.000328	CcSEcCtD
Voriconazole—Urinary tract infection—Doxorubicin—uterine cancer	0.000105	0.000328	CcSEcCtD
Voriconazole—Conjunctivitis—Doxorubicin—uterine cancer	0.000105	0.000328	CcSEcCtD
Voriconazole—Hepatitis—Epirubicin—uterine cancer	0.000105	0.000328	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	0.000105	0.00321	CbGpPWpGaD
Voriconazole—Hypoaesthesia—Epirubicin—uterine cancer	0.000105	0.000326	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000105	0.0032	CbGpPWpGaD
Voriconazole—Pharyngitis—Epirubicin—uterine cancer	0.000105	0.000325	CcSEcCtD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000104	0.00319	CbGpPWpGaD
Voriconazole—Sweating—Doxorubicin—uterine cancer	0.000104	0.000324	CcSEcCtD
Voriconazole—Urinary tract disorder—Epirubicin—uterine cancer	0.000104	0.000324	CcSEcCtD
Voriconazole—Oedema peripheral—Epirubicin—uterine cancer	0.000104	0.000323	CcSEcCtD
Voriconazole—FMO1—Metabolism—POLD1—uterine cancer	0.000104	0.00317	CbGpPWpGaD
Voriconazole—Haematuria—Doxorubicin—uterine cancer	0.000103	0.000322	CcSEcCtD
Voriconazole—Connective tissue disorder—Epirubicin—uterine cancer	0.000103	0.000322	CcSEcCtD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000103	0.00317	CbGpPWpGaD
Voriconazole—Urethral disorder—Epirubicin—uterine cancer	0.000103	0.000321	CcSEcCtD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000103	0.00315	CbGpPWpGaD
Voriconazole—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000103	0.00032	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	0.000103	0.00314	CbGpPWpGaD
Voriconazole—Epistaxis—Doxorubicin—uterine cancer	0.000102	0.000319	CcSEcCtD
Voriconazole—Sinusitis—Doxorubicin—uterine cancer	0.000102	0.000317	CcSEcCtD
Voriconazole—Visual impairment—Epirubicin—uterine cancer	0.000101	0.000316	CcSEcCtD
Voriconazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000101	0.000315	CcSEcCtD
Voriconazole—Erythema multiforme—Epirubicin—uterine cancer	9.96e-05	0.00031	CcSEcCtD
Voriconazole—Bradycardia—Doxorubicin—uterine cancer	9.92e-05	0.000309	CcSEcCtD
Voriconazole—FMO3—SIDS Susceptibility Pathways—VEGFA—uterine cancer	9.91e-05	0.00304	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	9.88e-05	0.00303	CbGpPWpGaD
Voriconazole—Eye disorder—Epirubicin—uterine cancer	9.84e-05	0.000306	CcSEcCtD
Voriconazole—Hypersensitivity—Etoposide—uterine cancer	9.83e-05	0.000306	CcSEcCtD
Voriconazole—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	9.83e-05	0.00301	CbGpPWpGaD
Voriconazole—Tinnitus—Epirubicin—uterine cancer	9.82e-05	0.000306	CcSEcCtD
Voriconazole—Cardiac disorder—Epirubicin—uterine cancer	9.77e-05	0.000304	CcSEcCtD
Voriconazole—Flushing—Epirubicin—uterine cancer	9.77e-05	0.000304	CcSEcCtD
Voriconazole—Rhinitis—Doxorubicin—uterine cancer	9.77e-05	0.000304	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	9.74e-05	0.00298	CbGpPWpGaD
Voriconazole—Hepatitis—Doxorubicin—uterine cancer	9.74e-05	0.000303	CcSEcCtD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	9.69e-05	0.00297	CbGpPWpGaD
Voriconazole—Hypoaesthesia—Doxorubicin—uterine cancer	9.69e-05	0.000302	CcSEcCtD
Voriconazole—FMO1—Metabolism—AKR1C1—uterine cancer	9.69e-05	0.00297	CbGpPWpGaD
Voriconazole—Pharyngitis—Doxorubicin—uterine cancer	9.67e-05	0.000301	CcSEcCtD
Voriconazole—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	9.66e-05	0.00296	CbGpPWpGaD
Voriconazole—Urinary tract disorder—Doxorubicin—uterine cancer	9.62e-05	0.0003	CcSEcCtD
Voriconazole—Oedema peripheral—Doxorubicin—uterine cancer	9.6e-05	0.000299	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	9.58e-05	0.00293	CbGpPWpGaD
Voriconazole—Asthenia—Etoposide—uterine cancer	9.57e-05	0.000298	CcSEcCtD
Voriconazole—Connective tissue disorder—Doxorubicin—uterine cancer	9.57e-05	0.000298	CcSEcCtD
Voriconazole—Angiopathy—Epirubicin—uterine cancer	9.55e-05	0.000297	CcSEcCtD
Voriconazole—Urethral disorder—Doxorubicin—uterine cancer	9.55e-05	0.000297	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—CYP19A1—uterine cancer	9.53e-05	0.00292	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	9.52e-05	0.00292	CbGpPWpGaD
Voriconazole—Immune system disorder—Epirubicin—uterine cancer	9.51e-05	0.000296	CcSEcCtD
Voriconazole—Mediastinal disorder—Epirubicin—uterine cancer	9.49e-05	0.000295	CcSEcCtD
Voriconazole—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	9.49e-05	0.0029	CbGpPWpGaD
Voriconazole—Chills—Epirubicin—uterine cancer	9.45e-05	0.000294	CcSEcCtD
Voriconazole—Pruritus—Etoposide—uterine cancer	9.44e-05	0.000294	CcSEcCtD
Voriconazole—FMO3—Metabolism—STAR—uterine cancer	9.43e-05	0.00289	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—AKR1B1—uterine cancer	9.43e-05	0.00289	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.43e-05	0.00289	CbGpPWpGaD
Voriconazole—Arrhythmia—Epirubicin—uterine cancer	9.41e-05	0.000293	CcSEcCtD
Voriconazole—Visual impairment—Doxorubicin—uterine cancer	9.39e-05	0.000292	CcSEcCtD
Voriconazole—Alopecia—Epirubicin—uterine cancer	9.3e-05	0.00029	CcSEcCtD
Voriconazole—Mental disorder—Epirubicin—uterine cancer	9.22e-05	0.000287	CcSEcCtD
Voriconazole—Erythema multiforme—Doxorubicin—uterine cancer	9.21e-05	0.000287	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	9.2e-05	0.00282	CbGpPWpGaD
Voriconazole—Erythema—Epirubicin—uterine cancer	9.17e-05	0.000285	CcSEcCtD
Voriconazole—Malnutrition—Epirubicin—uterine cancer	9.17e-05	0.000285	CcSEcCtD
Voriconazole—Diarrhoea—Etoposide—uterine cancer	9.13e-05	0.000284	CcSEcCtD
Voriconazole—Eye disorder—Doxorubicin—uterine cancer	9.1e-05	0.000283	CcSEcCtD
Voriconazole—Tinnitus—Doxorubicin—uterine cancer	9.08e-05	0.000283	CcSEcCtD
Voriconazole—Flushing—Doxorubicin—uterine cancer	9.04e-05	0.000281	CcSEcCtD
Voriconazole—Cardiac disorder—Doxorubicin—uterine cancer	9.04e-05	0.000281	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	9.03e-05	0.00277	CbGpPWpGaD
Voriconazole—Flatulence—Epirubicin—uterine cancer	9.03e-05	0.000281	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	8.99e-05	0.00275	CbGpPWpGaD
Voriconazole—Dysgeusia—Epirubicin—uterine cancer	8.98e-05	0.000279	CcSEcCtD
Voriconazole—Back pain—Epirubicin—uterine cancer	8.87e-05	0.000276	CcSEcCtD
Voriconazole—Angiopathy—Doxorubicin—uterine cancer	8.84e-05	0.000275	CcSEcCtD
Voriconazole—Dizziness—Etoposide—uterine cancer	8.82e-05	0.000275	CcSEcCtD
Voriconazole—Muscle spasms—Epirubicin—uterine cancer	8.81e-05	0.000274	CcSEcCtD
Voriconazole—Immune system disorder—Doxorubicin—uterine cancer	8.8e-05	0.000274	CcSEcCtD
Voriconazole—Mediastinal disorder—Doxorubicin—uterine cancer	8.78e-05	0.000273	CcSEcCtD
Voriconazole—Chills—Doxorubicin—uterine cancer	8.74e-05	0.000272	CcSEcCtD
Voriconazole—Arrhythmia—Doxorubicin—uterine cancer	8.7e-05	0.000271	CcSEcCtD
Voriconazole—Vision blurred—Epirubicin—uterine cancer	8.64e-05	0.000269	CcSEcCtD
Voriconazole—FMO1—Metabolism—RRM2—uterine cancer	8.63e-05	0.00264	CbGpPWpGaD
Voriconazole—Alopecia—Doxorubicin—uterine cancer	8.61e-05	0.000268	CcSEcCtD
Voriconazole—Mental disorder—Doxorubicin—uterine cancer	8.54e-05	0.000266	CcSEcCtD
Voriconazole—Ill-defined disorder—Epirubicin—uterine cancer	8.5e-05	0.000265	CcSEcCtD
Voriconazole—Vomiting—Etoposide—uterine cancer	8.48e-05	0.000264	CcSEcCtD
Voriconazole—Erythema—Doxorubicin—uterine cancer	8.48e-05	0.000264	CcSEcCtD
Voriconazole—Malnutrition—Doxorubicin—uterine cancer	8.48e-05	0.000264	CcSEcCtD
Voriconazole—Anaemia—Epirubicin—uterine cancer	8.47e-05	0.000264	CcSEcCtD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.45e-05	0.00259	CbGpPWpGaD
Voriconazole—Agitation—Epirubicin—uterine cancer	8.42e-05	0.000262	CcSEcCtD
Voriconazole—Rash—Etoposide—uterine cancer	8.41e-05	0.000262	CcSEcCtD
Voriconazole—Dermatitis—Etoposide—uterine cancer	8.41e-05	0.000262	CcSEcCtD
Voriconazole—FMO1—Metabolism—DCN—uterine cancer	8.38e-05	0.00257	CbGpPWpGaD
Voriconazole—Headache—Etoposide—uterine cancer	8.36e-05	0.00026	CcSEcCtD
Voriconazole—Flatulence—Doxorubicin—uterine cancer	8.36e-05	0.00026	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.31e-05	0.00254	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.31e-05	0.00254	CbGpPWpGaD
Voriconazole—Dysgeusia—Doxorubicin—uterine cancer	8.31e-05	0.000259	CcSEcCtD
Voriconazole—Malaise—Epirubicin—uterine cancer	8.27e-05	0.000257	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	8.24e-05	0.00252	CbGpPWpGaD
Voriconazole—Vertigo—Epirubicin—uterine cancer	8.23e-05	0.000256	CcSEcCtD
Voriconazole—Syncope—Epirubicin—uterine cancer	8.22e-05	0.000256	CcSEcCtD
Voriconazole—Leukopenia—Epirubicin—uterine cancer	8.2e-05	0.000255	CcSEcCtD
Voriconazole—Back pain—Doxorubicin—uterine cancer	8.2e-05	0.000255	CcSEcCtD
Voriconazole—Muscle spasms—Doxorubicin—uterine cancer	8.15e-05	0.000254	CcSEcCtD
Voriconazole—Palpitations—Epirubicin—uterine cancer	8.1e-05	0.000252	CcSEcCtD
Voriconazole—Loss of consciousness—Epirubicin—uterine cancer	8.06e-05	0.000251	CcSEcCtD
Voriconazole—Cough—Epirubicin—uterine cancer	8e-05	0.000249	CcSEcCtD
Voriconazole—Vision blurred—Doxorubicin—uterine cancer	7.99e-05	0.000249	CcSEcCtD
Voriconazole—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	7.96e-05	0.00244	CbGpPWpGaD
Voriconazole—Convulsion—Epirubicin—uterine cancer	7.94e-05	0.000247	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	7.93e-05	0.00243	CbGpPWpGaD
Voriconazole—Nausea—Etoposide—uterine cancer	7.93e-05	0.000247	CcSEcCtD
Voriconazole—Hypertension—Epirubicin—uterine cancer	7.91e-05	0.000246	CcSEcCtD
Voriconazole—FMO1—Metabolism—CYP11A1—uterine cancer	7.9e-05	0.00242	CbGpPWpGaD
Voriconazole—Ill-defined disorder—Doxorubicin—uterine cancer	7.87e-05	0.000245	CcSEcCtD
Voriconazole—Anaemia—Doxorubicin—uterine cancer	7.84e-05	0.000244	CcSEcCtD
Voriconazole—Myalgia—Epirubicin—uterine cancer	7.8e-05	0.000243	CcSEcCtD
Voriconazole—Chest pain—Epirubicin—uterine cancer	7.8e-05	0.000243	CcSEcCtD
Voriconazole—Arthralgia—Epirubicin—uterine cancer	7.8e-05	0.000243	CcSEcCtD
Voriconazole—Agitation—Doxorubicin—uterine cancer	7.79e-05	0.000243	CcSEcCtD
Voriconazole—Anxiety—Epirubicin—uterine cancer	7.78e-05	0.000242	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.75e-05	0.000241	CcSEcCtD
Voriconazole—Discomfort—Epirubicin—uterine cancer	7.71e-05	0.00024	CcSEcCtD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.67e-05	0.00235	CbGpPWpGaD
Voriconazole—Malaise—Doxorubicin—uterine cancer	7.65e-05	0.000238	CcSEcCtD
Voriconazole—Dry mouth—Epirubicin—uterine cancer	7.63e-05	0.000238	CcSEcCtD
Voriconazole—Vertigo—Doxorubicin—uterine cancer	7.62e-05	0.000237	CcSEcCtD
Voriconazole—Syncope—Doxorubicin—uterine cancer	7.61e-05	0.000237	CcSEcCtD
Voriconazole—Leukopenia—Doxorubicin—uterine cancer	7.59e-05	0.000236	CcSEcCtD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.57e-05	0.00232	CbGpPWpGaD
Voriconazole—Confusional state—Epirubicin—uterine cancer	7.54e-05	0.000235	CcSEcCtD
Voriconazole—Palpitations—Doxorubicin—uterine cancer	7.49e-05	0.000233	CcSEcCtD
Voriconazole—Anaphylactic shock—Epirubicin—uterine cancer	7.48e-05	0.000233	CcSEcCtD
Voriconazole—Oedema—Epirubicin—uterine cancer	7.48e-05	0.000233	CcSEcCtD
Voriconazole—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	7.47e-05	0.00229	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—AKR1C3—uterine cancer	7.46e-05	0.00228	CbGpPWpGaD
Voriconazole—Loss of consciousness—Doxorubicin—uterine cancer	7.45e-05	0.000232	CcSEcCtD
Voriconazole—Infection—Epirubicin—uterine cancer	7.43e-05	0.000231	CcSEcCtD
Voriconazole—FMO3—Metabolism—POLD1—uterine cancer	7.4e-05	0.00227	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	7.4e-05	0.00227	CbGpPWpGaD
Voriconazole—Cough—Doxorubicin—uterine cancer	7.4e-05	0.00023	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	7.36e-05	0.00225	CbGpPWpGaD
Voriconazole—Shock—Epirubicin—uterine cancer	7.36e-05	0.000229	CcSEcCtD
Voriconazole—Convulsion—Doxorubicin—uterine cancer	7.35e-05	0.000229	CcSEcCtD
Voriconazole—Nervous system disorder—Epirubicin—uterine cancer	7.34e-05	0.000228	CcSEcCtD
Voriconazole—Thrombocytopenia—Epirubicin—uterine cancer	7.32e-05	0.000228	CcSEcCtD
Voriconazole—Hypertension—Doxorubicin—uterine cancer	7.32e-05	0.000228	CcSEcCtD
Voriconazole—Tachycardia—Epirubicin—uterine cancer	7.3e-05	0.000227	CcSEcCtD
Voriconazole—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	7.27e-05	0.00223	CbGpPWpGaD
Voriconazole—Skin disorder—Epirubicin—uterine cancer	7.27e-05	0.000226	CcSEcCtD
Voriconazole—Hyperhidrosis—Epirubicin—uterine cancer	7.23e-05	0.000225	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	7.23e-05	0.00221	CbGpPWpGaD
Voriconazole—Chest pain—Doxorubicin—uterine cancer	7.22e-05	0.000225	CcSEcCtD
Voriconazole—Myalgia—Doxorubicin—uterine cancer	7.22e-05	0.000225	CcSEcCtD
Voriconazole—Arthralgia—Doxorubicin—uterine cancer	7.22e-05	0.000225	CcSEcCtD
Voriconazole—Anxiety—Doxorubicin—uterine cancer	7.2e-05	0.000224	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	7.17e-05	0.000223	CcSEcCtD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	7.17e-05	0.0022	CbGpPWpGaD
Voriconazole—Discomfort—Doxorubicin—uterine cancer	7.13e-05	0.000222	CcSEcCtD
Voriconazole—Anorexia—Epirubicin—uterine cancer	7.13e-05	0.000222	CcSEcCtD
Voriconazole—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	7.11e-05	0.00218	CbGpPWpGaD
Voriconazole—Dry mouth—Doxorubicin—uterine cancer	7.06e-05	0.00022	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	7.01e-05	0.00215	CbGpPWpGaD
Voriconazole—Hypotension—Epirubicin—uterine cancer	6.99e-05	0.000218	CcSEcCtD
Voriconazole—Confusional state—Doxorubicin—uterine cancer	6.98e-05	0.000217	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	6.95e-05	0.00213	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—AKR1C1—uterine cancer	6.92e-05	0.00212	CbGpPWpGaD
Voriconazole—Oedema—Doxorubicin—uterine cancer	6.92e-05	0.000215	CcSEcCtD
Voriconazole—Anaphylactic shock—Doxorubicin—uterine cancer	6.92e-05	0.000215	CcSEcCtD
Voriconazole—Infection—Doxorubicin—uterine cancer	6.88e-05	0.000214	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.82e-05	0.000212	CcSEcCtD
Voriconazole—Shock—Doxorubicin—uterine cancer	6.81e-05	0.000212	CcSEcCtD
Voriconazole—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	6.81e-05	0.00208	CbGpPWpGaD
Voriconazole—Nervous system disorder—Doxorubicin—uterine cancer	6.79e-05	0.000211	CcSEcCtD
Voriconazole—Thrombocytopenia—Doxorubicin—uterine cancer	6.78e-05	0.000211	CcSEcCtD
Voriconazole—Insomnia—Epirubicin—uterine cancer	6.77e-05	0.000211	CcSEcCtD
Voriconazole—Tachycardia—Doxorubicin—uterine cancer	6.76e-05	0.00021	CcSEcCtD
Voriconazole—Skin disorder—Doxorubicin—uterine cancer	6.72e-05	0.000209	CcSEcCtD
Voriconazole—Paraesthesia—Epirubicin—uterine cancer	6.72e-05	0.000209	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	6.71e-05	0.00206	CbGpPWpGaD
Voriconazole—Hyperhidrosis—Doxorubicin—uterine cancer	6.69e-05	0.000208	CcSEcCtD
Voriconazole—Dyspnoea—Epirubicin—uterine cancer	6.67e-05	0.000208	CcSEcCtD
Voriconazole—Somnolence—Epirubicin—uterine cancer	6.65e-05	0.000207	CcSEcCtD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.63e-05	0.00203	CbGpPWpGaD
Voriconazole—Anorexia—Doxorubicin—uterine cancer	6.6e-05	0.000205	CcSEcCtD
Voriconazole—Dyspepsia—Epirubicin—uterine cancer	6.58e-05	0.000205	CcSEcCtD
Voriconazole—Decreased appetite—Epirubicin—uterine cancer	6.5e-05	0.000202	CcSEcCtD
Voriconazole—Hypotension—Doxorubicin—uterine cancer	6.47e-05	0.000201	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Epirubicin—uterine cancer	6.46e-05	0.000201	CcSEcCtD
Voriconazole—Pain—Epirubicin—uterine cancer	6.4e-05	0.000199	CcSEcCtD
Voriconazole—Constipation—Epirubicin—uterine cancer	6.4e-05	0.000199	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	6.34e-05	0.00194	CbGpPWpGaD
Voriconazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.31e-05	0.000196	CcSEcCtD
Voriconazole—Insomnia—Doxorubicin—uterine cancer	6.26e-05	0.000195	CcSEcCtD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.22e-05	0.0019	CbGpPWpGaD
Voriconazole—Paraesthesia—Doxorubicin—uterine cancer	6.22e-05	0.000193	CcSEcCtD
Voriconazole—FMO3—Metabolism—RRM2—uterine cancer	6.17e-05	0.00189	CbGpPWpGaD
Voriconazole—Dyspnoea—Doxorubicin—uterine cancer	6.17e-05	0.000192	CcSEcCtD
Voriconazole—Feeling abnormal—Epirubicin—uterine cancer	6.16e-05	0.000192	CcSEcCtD
Voriconazole—Somnolence—Doxorubicin—uterine cancer	6.15e-05	0.000192	CcSEcCtD
Voriconazole—Gastrointestinal pain—Epirubicin—uterine cancer	6.12e-05	0.00019	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.1e-05	0.00187	CbGpPWpGaD
Voriconazole—Dyspepsia—Doxorubicin—uterine cancer	6.09e-05	0.00019	CcSEcCtD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.04e-05	0.00185	CbGpPWpGaD
Voriconazole—Decreased appetite—Doxorubicin—uterine cancer	6.02e-05	0.000187	CcSEcCtD
Voriconazole—FMO3—Metabolism—DCN—uterine cancer	5.99e-05	0.00183	CbGpPWpGaD
Voriconazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.98e-05	0.000186	CcSEcCtD
Voriconazole—Urticaria—Epirubicin—uterine cancer	5.94e-05	0.000185	CcSEcCtD
Voriconazole—Pain—Doxorubicin—uterine cancer	5.92e-05	0.000184	CcSEcCtD
Voriconazole—Constipation—Doxorubicin—uterine cancer	5.92e-05	0.000184	CcSEcCtD
Voriconazole—Body temperature increased—Epirubicin—uterine cancer	5.91e-05	0.000184	CcSEcCtD
Voriconazole—Abdominal pain—Epirubicin—uterine cancer	5.91e-05	0.000184	CcSEcCtD
Voriconazole—FMO1—Metabolism—CYP19A1—uterine cancer	5.81e-05	0.00178	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—STK11—uterine cancer	5.81e-05	0.00178	CbGpPWpGaD
Voriconazole—Feeling abnormal—Doxorubicin—uterine cancer	5.7e-05	0.000178	CcSEcCtD
Voriconazole—Gastrointestinal pain—Doxorubicin—uterine cancer	5.66e-05	0.000176	CcSEcCtD
Voriconazole—FMO3—Metabolism—CYP11A1—uterine cancer	5.64e-05	0.00173	CbGpPWpGaD
Voriconazole—Hypersensitivity—Epirubicin—uterine cancer	5.51e-05	0.000172	CcSEcCtD
Voriconazole—Urticaria—Doxorubicin—uterine cancer	5.5e-05	0.000171	CcSEcCtD
Voriconazole—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	5.49e-05	0.00168	CbGpPWpGaD
Voriconazole—Abdominal pain—Doxorubicin—uterine cancer	5.47e-05	0.00017	CcSEcCtD
Voriconazole—Body temperature increased—Doxorubicin—uterine cancer	5.47e-05	0.00017	CcSEcCtD
Voriconazole—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	5.43e-05	0.00166	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	5.42e-05	0.00166	CbGpPWpGaD
Voriconazole—Asthenia—Epirubicin—uterine cancer	5.37e-05	0.000167	CcSEcCtD
Voriconazole—FMO3—Metabolism—AKR1C3—uterine cancer	5.33e-05	0.00163	CbGpPWpGaD
Voriconazole—Pruritus—Epirubicin—uterine cancer	5.29e-05	0.000165	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—SRD5A2—uterine cancer	5.28e-05	0.00162	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NDUFB11—uterine cancer	5.28e-05	0.00162	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—SRD5A2—uterine cancer	5.12e-05	0.00157	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—NDUFB11—uterine cancer	5.12e-05	0.00157	CbGpPWpGaD
Voriconazole—Diarrhoea—Epirubicin—uterine cancer	5.12e-05	0.000159	CcSEcCtD
Voriconazole—Hypersensitivity—Doxorubicin—uterine cancer	5.1e-05	0.000159	CcSEcCtD
Voriconazole—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	5.01e-05	0.00153	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.97e-05	0.00152	CbGpPWpGaD
Voriconazole—Asthenia—Doxorubicin—uterine cancer	4.97e-05	0.000155	CcSEcCtD
Voriconazole—Dizziness—Epirubicin—uterine cancer	4.95e-05	0.000154	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	4.94e-05	0.00151	CbGpPWpGaD
Voriconazole—Pruritus—Doxorubicin—uterine cancer	4.9e-05	0.000152	CcSEcCtD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.79e-05	0.00147	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.79e-05	0.00147	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	4.77e-05	0.00146	CbGpPWpGaD
Voriconazole—Vomiting—Epirubicin—uterine cancer	4.76e-05	0.000148	CcSEcCtD
Voriconazole—Diarrhoea—Doxorubicin—uterine cancer	4.74e-05	0.000147	CcSEcCtD
Voriconazole—Rash—Epirubicin—uterine cancer	4.72e-05	0.000147	CcSEcCtD
Voriconazole—Dermatitis—Epirubicin—uterine cancer	4.71e-05	0.000147	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.7e-05	0.00144	CbGpPWpGaD
Voriconazole—Headache—Epirubicin—uterine cancer	4.69e-05	0.000146	CcSEcCtD
Voriconazole—Dizziness—Doxorubicin—uterine cancer	4.58e-05	0.000142	CcSEcCtD
Voriconazole—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.49e-05	0.00137	CbGpPWpGaD
Voriconazole—Nausea—Epirubicin—uterine cancer	4.44e-05	0.000138	CcSEcCtD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.43e-05	0.00136	CbGpPWpGaD
Voriconazole—Vomiting—Doxorubicin—uterine cancer	4.4e-05	0.000137	CcSEcCtD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.37e-05	0.00134	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.37e-05	0.00134	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—MTHFR—uterine cancer	4.37e-05	0.00134	CbGpPWpGaD
Voriconazole—Rash—Doxorubicin—uterine cancer	4.36e-05	0.000136	CcSEcCtD
Voriconazole—Dermatitis—Doxorubicin—uterine cancer	4.36e-05	0.000136	CcSEcCtD
Voriconazole—Headache—Doxorubicin—uterine cancer	4.34e-05	0.000135	CcSEcCtD
Voriconazole—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.18e-05	0.00128	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—STK11—uterine cancer	4.15e-05	0.00127	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CYP19A1—uterine cancer	4.15e-05	0.00127	CbGpPWpGaD
Voriconazole—Nausea—Doxorubicin—uterine cancer	4.11e-05	0.000128	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—SRD5A2—uterine cancer	3.91e-05	0.0012	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—NDUFB11—uterine cancer	3.91e-05	0.0012	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—AKR1B1—uterine cancer	3.82e-05	0.00117	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—STAR—uterine cancer	3.82e-05	0.00117	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—SRD5A2—uterine cancer	3.82e-05	0.00117	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NDUFB11—uterine cancer	3.82e-05	0.00117	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—STAR—uterine cancer	3.7e-05	0.00113	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—AKR1B1—uterine cancer	3.7e-05	0.00113	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.66e-05	0.00112	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.52e-05	0.00108	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.3e-05	0.00101	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.26e-05	0.000997	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.21e-05	0.000982	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—MTHFR—uterine cancer	3.12e-05	0.000955	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—POLD1—uterine cancer	3e-05	0.000917	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.95e-05	0.000904	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.95e-05	0.000904	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—POLD1—uterine cancer	2.9e-05	0.000889	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.87e-05	0.000878	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—AKR1B1—uterine cancer	2.82e-05	0.000865	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—STAR—uterine cancer	2.82e-05	0.000865	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—AKR1C1—uterine cancer	2.8e-05	0.000858	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—AKR1B1—uterine cancer	2.76e-05	0.000845	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—STAR—uterine cancer	2.76e-05	0.000845	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—AKR1C1—uterine cancer	2.72e-05	0.000832	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.71e-05	0.000829	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.69e-05	0.000824	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.69e-05	0.000824	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.61e-05	0.0008	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—RRM2—uterine cancer	2.5e-05	0.000765	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.47e-05	0.000756	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTEN—uterine cancer	2.43e-05	0.000744	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—DCN—uterine cancer	2.43e-05	0.000743	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—RRM2—uterine cancer	2.42e-05	0.000741	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—DCN—uterine cancer	2.35e-05	0.00072	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—EP300—uterine cancer	2.32e-05	0.000709	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CYP11A1—uterine cancer	2.28e-05	0.0007	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—POLD1—uterine cancer	2.22e-05	0.000678	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP11A1—uterine cancer	2.21e-05	0.000678	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—POLD1—uterine cancer	2.17e-05	0.000663	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—AKR1C3—uterine cancer	2.16e-05	0.000661	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—STAR—uterine cancer	2.13e-05	0.000653	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.13e-05	0.000653	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.11e-05	0.000646	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—AKR1C3—uterine cancer	2.09e-05	0.00064	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.07e-05	0.000635	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.03e-05	0.00062	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—STAR—uterine cancer	1.95e-05	0.000596	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.95e-05	0.000596	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.92e-05	0.000589	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—RRM2—uterine cancer	1.85e-05	0.000566	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—RRM2—uterine cancer	1.81e-05	0.000553	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—DCN—uterine cancer	1.79e-05	0.000549	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.77e-05	0.000543	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.77e-05	0.000543	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—DCN—uterine cancer	1.75e-05	0.000537	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTEN—uterine cancer	1.74e-05	0.000532	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PIK3CA—uterine cancer	1.71e-05	0.000525	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.69e-05	0.000517	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—STK11—uterine cancer	1.68e-05	0.000515	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.68e-05	0.000515	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—POLD1—uterine cancer	1.67e-05	0.000513	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—EP300—uterine cancer	1.66e-05	0.000507	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.65e-05	0.000506	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—STK11—uterine cancer	1.63e-05	0.000499	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP19A1—uterine cancer	1.63e-05	0.000499	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.6e-05	0.000489	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.57e-05	0.00048	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.56e-05	0.000478	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.53e-05	0.000468	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—POLD1—uterine cancer	1.53e-05	0.000467	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.46e-05	0.000447	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.43e-05	0.000437	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—AKT1—uterine cancer	1.4e-05	0.000429	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—RRM2—uterine cancer	1.4e-05	0.000427	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—DCN—uterine cancer	1.36e-05	0.000415	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.28e-05	0.000393	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—STAR—uterine cancer	1.28e-05	0.000393	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.28e-05	0.000391	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—RRM2—uterine cancer	1.27e-05	0.00039	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—MTHFR—uterine cancer	1.26e-05	0.000387	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—STK11—uterine cancer	1.24e-05	0.000381	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.24e-05	0.000381	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—DCN—uterine cancer	1.24e-05	0.000378	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PIK3CA—uterine cancer	1.22e-05	0.000375	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—MTHFR—uterine cancer	1.22e-05	0.000375	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—STK11—uterine cancer	1.22e-05	0.000372	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.22e-05	0.000372	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.21e-05	0.000369	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.16e-05	0.000356	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.1e-05	0.000337	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.08e-05	0.00033	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—POLD1—uterine cancer	1.01e-05	0.000308	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—AKT1—uterine cancer	1e-05	0.000306	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.42e-06	0.000288	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—STK11—uterine cancer	9.39e-06	0.000288	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP19A1—uterine cancer	9.39e-06	0.000288	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—MTHFR—uterine cancer	9.34e-06	0.000286	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—MTHFR—uterine cancer	9.13e-06	0.00028	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.82e-06	0.00027	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—STK11—uterine cancer	8.57e-06	0.000262	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP19A1—uterine cancer	8.57e-06	0.000262	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.41e-06	0.000257	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—RRM2—uterine cancer	8.4e-06	0.000257	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—DCN—uterine cancer	8.15e-06	0.00025	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.04e-06	0.000246	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP11A1—uterine cancer	7.68e-06	0.000235	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.67e-06	0.000235	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.25e-06	0.000222	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—MTHFR—uterine cancer	7.06e-06	0.000216	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTEN—uterine cancer	7.03e-06	0.000215	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTEN—uterine cancer	6.81e-06	0.000209	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—EP300—uterine cancer	6.7e-06	0.000205	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—EP300—uterine cancer	6.5e-06	0.000199	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—MTHFR—uterine cancer	6.44e-06	0.000197	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.22e-06	0.00019	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.67e-06	0.000174	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.65e-06	0.000173	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—STK11—uterine cancer	5.65e-06	0.000173	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTEN—uterine cancer	5.2e-06	0.000159	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTEN—uterine cancer	5.08e-06	0.000156	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PIK3CA—uterine cancer	4.96e-06	0.000152	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—EP300—uterine cancer	4.96e-06	0.000152	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—EP300—uterine cancer	4.84e-06	0.000148	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PIK3CA—uterine cancer	4.81e-06	0.000147	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—MTHFR—uterine cancer	4.24e-06	0.00013	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—AKT1—uterine cancer	4.05e-06	0.000124	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTEN—uterine cancer	3.93e-06	0.00012	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—AKT1—uterine cancer	3.93e-06	0.00012	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—EP300—uterine cancer	3.75e-06	0.000115	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.67e-06	0.000112	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.58e-06	0.00011	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTEN—uterine cancer	3.58e-06	0.00011	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—EP300—uterine cancer	3.41e-06	0.000105	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—AKT1—uterine cancer	2.99e-06	9.17e-05	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—AKT1—uterine cancer	2.93e-06	8.96e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.77e-06	8.48e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.53e-06	7.73e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTEN—uterine cancer	2.36e-06	7.23e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—AKT1—uterine cancer	2.26e-06	6.93e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—EP300—uterine cancer	2.25e-06	6.9e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—AKT1—uterine cancer	2.06e-06	6.32e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.67e-06	5.1e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—AKT1—uterine cancer	1.36e-06	4.17e-05	CbGpPWpGaD
